Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Pharmacovigilance Recall Procedures

Posted on By

SOP for Pharmacovigilance Recall Procedures

Guidelines for Pharmacovigilance Recall Procedures

1) Purpose

The purpose of this SOP is to establish procedures for the recall of pharmaceutical products from the market in response to pharmacovigilance data indicating potential safety risks.

2) Scope

This SOP applies to all pharmacovigilance and quality assurance personnel involved in the recall process, including pharmacovigilance managers, regulatory affairs specialists, and quality control officers.

3) Responsibilities

The Recall Management Team is responsible for coordinating and executing recall procedures. The Pharmacovigilance (PV) Manager oversees recall activities to ensure they are conducted in compliance with regulatory requirements and company policies.

4) Procedure

4.1 Initiation of Recall

  1. Identify the need for a recall based on pharmacovigilance data, adverse event reports, or regulatory notifications.
  2. Notify senior management and regulatory authorities of the decision to initiate a recall.
  3. Form a Recall Management Team comprising pharmacovigilance, regulatory affairs, quality assurance, and supply chain representatives.
See also  SOP for Pharmacovigilance Stakeholder Communication

4.2 Recall Classification

  1. Determine the classification of the recall (Class I, II, or III) based on the severity of the risk to patients.
  2. Document the rationale for the recall classification and obtain approval from the PV Manager and regulatory affairs.

4.3 Notification and Communication

  1. Prepare and distribute recall notifications to healthcare providers, distributors, and regulatory authorities.
  2. Provide clear instructions for the return or destruction of the recalled product.
  3. Maintain open lines of communication with all stakeholders throughout the recall process.

4.4 Product Retrieval

  1. Coordinate with supply chain and distribution teams to retrieve the recalled product from the market.
  2. Ensure proper documentation and tracking of returned products.
  3. Conduct inspections of returned products to assess compliance with recall instructions.
See also  SOP for Pharmacovigilance Compliance Policy

4.5 Root Cause Analysis

  1. Conduct a thorough investigation to determine the root cause of the issue leading to the recall.
  2. Document findings and implement corrective and preventive actions (CAPAs) to prevent recurrence.
  3. Review and update relevant SOPs, processes, and training materials based on investigation outcomes.

4.6 Reporting and Documentation

  1. Prepare and submit recall reports to regulatory authorities, detailing the scope, classification, and outcome of the recall.
  2. Maintain records of all recall-related activities, communications, and documents for audit and inspection purposes.
  3. Conduct post-recall reviews to assess the effectiveness of the recall process and identify areas for improvement.

5) Abbreviations, if any

PV – Pharmacovigilance, SOP – Standard Operating Procedure, CAPA – Corrective and Preventive Actions

See also  Pharmacovigilance: SOP for Pharmacovigilance Regulatory Intelligence Monitoring

6) Documents, if any

Recall notifications, recall classification documentation, product return logs, root cause analysis reports, CAPA records.

7) Reference, if any

FDA Guidance for Industry – Product Recalls, Including Removals and Corrections, EU Guidelines on Good Distribution Practice (GDP) of Medicinal Products for Human Use.

8) SOP Version

Version 1.0

Pharmacovigilance Tags:Pharmacovigilance adverse event reporting SOP, Pharmacovigilance audit preparation SOP, Pharmacovigilance case processing SOP, Pharmacovigilance compliance monitoring SOP, Pharmacovigilance compliance SOP, Pharmacovigilance data collection SOP, Pharmacovigilance data privacy SOP, Pharmacovigilance database management SOP, Pharmacovigilance documentation management SOP, Pharmacovigilance guidelines, Pharmacovigilance literature review SOP, Pharmacovigilance medical review SOP, Pharmacovigilance periodic reporting SOP, Pharmacovigilance procedure document, Pharmacovigilance quality management SOP, Pharmacovigilance regulatory reporting SOP, Pharmacovigilance risk assessment SOP, Pharmacovigilance risk management plan SOP, Pharmacovigilance risk minimization SOP, Pharmacovigilance safety reporting SOP, Pharmacovigilance signal detection SOP, Pharmacovigilance signal management SOP, Pharmacovigilance SOP template, Pharmacovigilance system master file SOP, Pharmacovigilance training program SOP

Post navigation

Previous Post: SOP for Energy Control Procedures in Transdermal Patches Production
Next Post: SOP for Batch Record Review in Transdermal Patches Production

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version